Artiva Biotherapeutics (ARTV) Liabilities and Shareholders Equity (2023 - 2026)
Artiva Biotherapeutics' Liabilities and Shareholders Equity came in at $368.63 million for Q2 2026, up 117.6% from $169.39 million a year earlier and up 247.9% from the prior quarter.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Artiva Biotherapeutics' Liabilities and Shareholders Equity was $130.94 million, down 37.5% from FY2024.
- Going back by year, Liabilities and Shareholders Equity was $209.58 million in FY2024 (+99.4%) and $105.11 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2023.
- Year-over-year, Liabilities and Shareholders Equity increased in three of the last six quarters, with growth averaging 37.3%.
- Business Quant data shows ARTV's Liabilities and Shareholders Equity at $105.96 million (Q1 2026), $130.94 million (Q4 2025) and $148.86 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Artiva Biotherapeutics | 280.62 Mn | 280.62 Mn | - | 368.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 368.63 Mn |
| Mar 31, 2026 | 105.96 Mn |
| Dec 31, 2025 | 130.94 Mn |
| Sep 30, 2025 | 148.86 Mn |
| Jun 30, 2025 | 169.39 Mn |
| Mar 31, 2025 | 191.26 Mn |
| Dec 31, 2024 | 209.58 Mn |
| Sep 30, 2024 | 225.60 Mn |
| Jun 30, 2024 | 75.91 Mn |
| Dec 31, 2023 | 105.11 Mn |
API Access
Artiva Biotherapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();